Aztreonam and Halaven drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aztreonam (aztreonam) and Halaven (eribulin mesylate). Common drug interactions include coagulopathy among females.

The phase IV clinical study analyzes what interactions people have when they take Aztreonam and Halaven. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Aztreonam?

Aztreonam has active ingredients of aztreonam. eHealthMe is studying from 3,054 Aztreonam users. Check the latest studies of Aztreonam.

What is Halaven?

Halaven has active ingredients of eribulin mesylate. eHealthMe is studying from 3,881 Halaven users. Check the latest studies of Halaven.



On Jul, 19, 2026

19 people who take Aztreonam and Halaven together, and have interactions are studied.

Aztreonam and Halaven drug interactions.

What are the common drug interactions of Aztreonam and Halaven, by gender? *:

female:

  1. Coagulopathy (blood's ability to clot is impaired)
  2. Neuropathy peripheral (surface nerve damage)
  3. Lung infection
  4. Respiratory failure (inadequate gas exchange by the respiratory system)

male:

n/a

What are the common drug interactions of Aztreonam and Halaven, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Coagulopathy (blood's ability to clot is impaired)
  2. Neuropathy peripheral (surface nerve damage)

60+:

  1. Lung infection
  2. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

  1. Abdominal Pain: 19 people, 100.00%
  2. Gastric Ulcer (stomach ulcer): 18 people, 94.74%
  3. Abdominal Pain Upper: 18 people, 94.74%
  4. Biliary Sepsis: 18 people, 94.74%
  5. Blepharitis (chronic inflammation of the eyelid): 18 people, 94.74%
  6. Breast Cancer: 18 people, 94.74%
  7. Cholecystitis Acute (rapid infection of gallbladder): 18 people, 94.74%
  8. Folliculitis (infection of hair root): 18 people, 94.74%
  9. Thrombosis (formation of a blood clot inside a blood vessel): 18 people, 94.74%
  10. Gastritis (inflammation of stomach): 18 people, 94.74%

* Approximation only. Some reports may have incomplete information.

Do you take Aztreonam and Halaven?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aztreonam and Halaven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aztreonam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Halaven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aztreonam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Halaven and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam and eribulin mesylate (the active ingredients of Aztreonam and Halaven, respectively), and Aztreonam and Halaven (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: